Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets.<br /><br />Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. In parallel with the commercialisation of this product, Nanosonics is also developing other medical applications and exploring opportunities for its proprietary technology in other industries.
Nanosonics Limited
ASX:NAN ISIN:AU000000NAN9
新闻
###
33,830 公司背景浏览
- 本页浏览人次: (过去7日: 12) (过去30日: 60) (自发布以来: 9103)